Literature DB >> 1573788

Quality control of surgical technique in a multicenter, prospective, randomized, controlled study on the surgical treatment of gastric cancer.

M Sasako1, K Maruyama, T Kinoshita, J J Bonenkamp, C J van de Velde, J Hermans.   

Abstract

To evaluate the effect of lymph node dissection on gastric cancer patients operated upon with curative intent, we are carrying out a multicenter, prospective, randomized, controlled study in the Netherlands. The trial compares conventional gastrectomy to gastrectomy with extended lymph node dissection. In the first four months, a Japanese supervisor attended all the extended surgery and instructed many Dutch surgeons, including the eight consulting surgeons; since then, all extended gastrectomies have been attended by one of the consulting surgeons. The study coordinator attended all conventional cases. This assured that the quality of the extended surgery was as good as the Japanese standard, of which excellent results have been reported. To achieve this quality control, randomization before surgery was obligatory for practical reasons. Curability assessment at laparotomy, however, is done quite objectively with histological proof, except for the judgement of irresectability. Although this has resulted in many non-curative cases being randomized but subsequently not given the allocated surgery, the sample size should be sufficient to allow analysis according to randomization or the initial "intention to treat." This is the first protocol for a multicenter trial in surgical oncology to have such excellent surgical quality control and to assure a quality as high as that in the original report with uniformity in the level of technique. In studies comparing surgical techniques, it is vital that attention should be given to surgical quality control, otherwise survival rates may show little improvement and fail to make any impact on surgical practice.

Entities:  

Mesh:

Year:  1992        PMID: 1573788

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  7 in total

Review 1.  Lymphadenectomy for gastric cancer in clinical trials: update.

Authors:  J D Roder; J J Bonenkamp; J Craven; C J van de Velde; M Sasako; K Böttcher; H J Stein
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

2.  Clinical trials of surgical treatment of malignant diseases.

Authors:  Mitsuru Sasako
Journal:  Int J Clin Oncol       Date:  2005-06       Impact factor: 3.402

3.  Cancer of the stomach: a review of two hospitals in Korea and Japan.

Authors:  W J Lee; K M Chen
Journal:  World J Surg       Date:  1995 May-Jun       Impact factor: 3.352

4.  Time-dependent changes in CT of radiation-induced liver injury: a preliminary study in gastric cancer patients.

Authors:  Yaqi Sheng; Qiuxia Wang; Zhen Li; Nannan Zheng; Yigang Pei; Liang Chen; Dayu Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-11-10

5.  Comparison of factors influencing the prognosis of Japanese, German, and Dutch gastric cancer patients.

Authors:  J J Bonenkamp; C J van de Velde; G H Kampschöer; J Hermans; P Hermanek; M Bemelmans; D J Gouma; M Sasako; K Maruyama
Journal:  World J Surg       Date:  1993 May-Jun       Impact factor: 3.352

6.  Localized gastric or gastroesophageal cancer - chemoradiation is a pertinent component of adjuvant treatment for patients at high risk of relapse.

Authors:  Leonard L Gunderson; Matthew D Callister; Dawn E Jaroszewski; Helen J Ross; Mitesh J Borad; Richard J Gray; Louis A Lanza; Kristi L Harold; Barbara A Pockaj; Victor F Trastek
Journal:  Gastrointest Cancer Res       Date:  2009-03

Review 7.  Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward.

Authors:  Konstantinos Papadimitriou; Georgios Antoniou; Christian Rolfo; Antonio Russo; Giuseppe Bronte; Vassilios Vassiliou; Demetris Papamichael; Marc Peeters; Panteleimon Kountourakis
Journal:  Gastroenterol Res Pract       Date:  2015-05-26       Impact factor: 2.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.